BACKGROUND: Reliable stability and yield of RNA from breast cancer tissues are important for biobanking, clinical trials, and diagnostic testing. METHODS: Aliquots of fresh primary tumor tissue from 17 surgically resected invasive breast cancers were placed into RNAlater at room temperature after tumor removal (baseline) and up to 3 hours thereafter or were snap frozen at baseline and 40 minutes thereafter. Samples were stored at -80°C until gene expression profiling with Affymetrix Human Gene U133A microarrays. We evaluated the effects of cold ischemic time (the time from tumor specimen removal to sample preservation) and sample preservation method on RNA yield, Bioanalyzer-based RNA integrity number, microarray-based 3'/5' expression ratios for assessing transcript integrity, and microarray-based measurement of single-gene and multigene expression signatures. The statistical significance of the effects was assessed using linear mixed effects regression models. All statistical tests were two-sided. RESULTS: Sample preservation in RNAlater statistically significantly improved RNA integrity compared with snap freezing as assessed by the RNA integrity number, which increased from 7.31 to 8.13 units (difference = 0.82 units, 95% confidence interval [CI] = 0.53 to 1.11 units, P < .001), and RNA yield, which increased threefold from 8.9 to 28.6 μg (difference = 19.7 μg, 95% CI = 14.1 to 25.3 μg, P < .001). Prolonged cold ischemic delay at room temperature before sample stabilization decreased the RNA integrity number by 0.12 units/h (95% CI = 0.02 to 0.23 units/h) compared with a projected average RNA integrity number of 7.39 if no delays were present (P = .008) and decreased the RNA yield by 1.5 μg/h (95% CI = 0 to 4 μg/h) from a baseline mean RNA yield of 33.5 μg if no delays were present (P = .019). Prolonged cold ischemia statistically significantly increased the 3'/5' ratio of control gene transcripts, particularly of STAT1 (P < .001). Snap freezing statistically significantly increased the 3'/5' ratio of three control transcripts (ACTB, GAPDH, and 18S rRNA). Expression levels of single genes and multigene signatures for breast cancer were largely unaffected by sample preservation method or cold ischemia. CONCLUSIONS: Sample preservation in RNAlater improves RNA yield and quality, whereas cold ischemia increases RNA fragmentation as measured by the 3'/5' expression ratio of control genes. However, expression levels of single genes and multigene signatures that are of diagnostic relevance in breast cancer were mostly unaffected by sample preservation method or prolonged cold ischemic duration.
BACKGROUND: Reliable stability and yield of RNA from breast cancer tissues are important for biobanking, clinical trials, and diagnostic testing. METHODS: Aliquots of fresh primary tumor tissue from 17 surgically resected invasive breast cancers were placed into RNAlater at room temperature after tumor removal (baseline) and up to 3 hours thereafter or were snap frozen at baseline and 40 minutes thereafter. Samples were stored at -80°C until gene expression profiling with Affymetrix Human Gene U133A microarrays. We evaluated the effects of cold ischemic time (the time from tumor specimen removal to sample preservation) and sample preservation method on RNA yield, Bioanalyzer-based RNA integrity number, microarray-based 3'/5' expression ratios for assessing transcript integrity, and microarray-based measurement of single-gene and multigene expression signatures. The statistical significance of the effects was assessed using linear mixed effects regression models. All statistical tests were two-sided. RESULTS: Sample preservation in RNAlater statistically significantly improved RNA integrity compared with snap freezing as assessed by the RNA integrity number, which increased from 7.31 to 8.13 units (difference = 0.82 units, 95% confidence interval [CI] = 0.53 to 1.11 units, P < .001), and RNA yield, which increased threefold from 8.9 to 28.6 μg (difference = 19.7 μg, 95% CI = 14.1 to 25.3 μg, P < .001). Prolonged cold ischemic delay at room temperature before sample stabilization decreased the RNA integrity number by 0.12 units/h (95% CI = 0.02 to 0.23 units/h) compared with a projected average RNA integrity number of 7.39 if no delays were present (P = .008) and decreased the RNA yield by 1.5 μg/h (95% CI = 0 to 4 μg/h) from a baseline mean RNA yield of 33.5 μg if no delays were present (P = .019). Prolonged cold ischemia statistically significantly increased the 3'/5' ratio of control gene transcripts, particularly of STAT1 (P < .001). Snap freezing statistically significantly increased the 3'/5' ratio of three control transcripts (ACTB, GAPDH, and 18S rRNA). Expression levels of single genes and multigene signatures for breast cancer were largely unaffected by sample preservation method or cold ischemia. CONCLUSIONS: Sample preservation in RNAlater improves RNA yield and quality, whereas cold ischemia increases RNA fragmentation as measured by the 3'/5' expression ratio of control genes. However, expression levels of single genes and multigene signatures that are of diagnostic relevance in breast cancer were mostly unaffected by sample preservation method or prolonged cold ischemic duration.
Authors: Fiona H Blackhall; Melania Pintilie; Dennis A Wigle; Igor Jurisica; Ni Liu; Nikolina Radulovich; Michael R Johnston; Shaf Keshavjee; Ming-Sound Tsao Journal: Neoplasia Date: 2004 Nov-Dec Impact factor: 5.715
Authors: Roger D Canales; Yuling Luo; James C Willey; Bradley Austermiller; Catalin C Barbacioru; Cecilie Boysen; Kathryn Hunkapiller; Roderick V Jensen; Charles R Knight; Kathleen Y Lee; Yunqing Ma; Botoul Maqsodi; Adam Papallo; Elizabeth Herness Peters; Karen Poulter; Patricia L Ruppel; Raymond R Samaha; Leming Shi; Wen Yang; Lu Zhang; Federico M Goodsaid Journal: Nat Biotechnol Date: 2006-09 Impact factor: 54.908
Authors: Brian R Leyland-Jones; Christine B Ambrosone; John Bartlett; Matthew J C Ellis; Rebecca A Enos; Adekunle Raji; Michael R Pins; Jo Anne Zujewski; Stephen M Hewitt; John F Forbes; Mark Abramovitz; Sofia Braga; Fatima Cardoso; Nadia Harbeck; Carsten Denkert; Scott D Jewell Journal: J Clin Oncol Date: 2008-10-27 Impact factor: 44.544
Authors: Daniel W Lin; Ilsa M Coleman; Sarah Hawley; Chung Y Huang; Ruth Dumpit; David Gifford; Philip Kezele; Hau Hung; Beatrice S Knudsen; Alan R Kristal; Peter S Nelson Journal: J Clin Oncol Date: 2006-07-05 Impact factor: 44.544
Authors: Scott D Jewell; Mythily Srinivasan; Linda M McCart; Nita Williams; William H Grizzle; Virginia LiVolsi; Greg MacLennan; Daniel D Sedmak Journal: Am J Clin Pathol Date: 2002-11 Impact factor: 2.493
Authors: Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard Journal: J Clin Oncol Date: 2009-02-09 Impact factor: 44.544
Authors: Loris De Cecco; Valeria Musella; Silvia Veneroni; Vera Cappelletti; Italia Bongarzone; Maurizio Callari; Barbara Valeri; Marco A Pierotti; Maria Grazia Daidone Journal: BMC Cancer Date: 2009-11-24 Impact factor: 4.430
Authors: L M Wolfe; R D Thiagarajan; F Boscolo; V Taché; R L Coleman; J Kim; W K Kwan; J F Loring; M Parast; L C Laurent Journal: Placenta Date: 2014-06-06 Impact factor: 3.481
Authors: John E Baatz; Danforth A Newton; Ellen C Riemer; Chadrick E Denlinger; E Ellen Jones; Richard R Drake; Demetri D Spyropoulos Journal: In Vivo Date: 2014 Jul-Aug Impact factor: 2.155
Authors: Douglas G Walker; Alexis M Whetzel; Geidy Serrano; Lucia I Sue; Lih-Fen Lue; Thomas G Beach Journal: Cell Tissue Bank Date: 2016-04-16 Impact factor: 1.522
Authors: Nicole M Martin; Katherine M Cooke; Caitlin C Radford; Lauren E Perley; Michelle Silasi; Clare A Flannery Journal: Am J Reprod Immunol Date: 2017-01-31 Impact factor: 3.886
Authors: Veronique M Neumeister; Valsamo Anagnostou; Summar Siddiqui; Allison Michal England; Elizabeth R Zarrella; Maria Vassilakopoulou; Fabio Parisi; Yuval Kluger; David G Hicks; David L Rimm Journal: J Natl Cancer Inst Date: 2012-10-22 Impact factor: 13.506
Authors: Marvaretta Stevenson; Jared Christensen; Debra Shoemaker; Traci Foster; William T Barry; Betty C Tong; Momen Wahidi; Scott Shofer; Michael Datto; Geoffrey Ginsburg; Jeffrey Crawford; Thomas D'Amico; Neal Ready Journal: Cancer Invest Date: 2014-05-09 Impact factor: 2.176